Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Short Interest Update

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totaling 246 shares, an increase of ∞ from the April 30th total of 0 shares. Based on an average trading volume of 186 shares, the short-interest ratio is presently 1.3 days.

Hikma Pharmaceuticals Trading Down 0.5%

Shares of OTCMKTS:HKMPY traded down $0.18 during trading on Tuesday, reaching $39.00. The company had a trading volume of 169 shares, compared to its average volume of 1,537. The firm’s fifty day moving average is $36.98 and its 200 day moving average is $39.40. Hikma Pharmaceuticals has a twelve month low of $31.80 and a twelve month high of $56.20.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.

The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.